Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.

作者: Chie Nishioka , Takayuki Ikezoe , Jing Yang , Sigal Gery , H. Phillip Koeffler

DOI: 10.1002/IJC.24472

关键词: EndocrinologyTretinoinHL60Cancer researchCell growthCell cycleBiologyCell cultureCellular differentiationmTORC1Retinoic acidInternal medicine

摘要: Our study explored the drug interaction of all-trans retinoic acid (ATRA) and RAD001 (everolimus), inhibitor mammalian target rapamycin complex 1 (mTORC1), in acute myelogenous leukemia (AML) NB4 HL60 cells. (10 nM) significantly enhanced ATRA-induced growth arrest differentiation these cells, as measured by colony-forming assay cell cycle analysis, expression CD11b surface antigen nitroblue tetrazolium reduction, respectively. ATRA (0.1-1 microM) upregulated levels RTP801, a negative regulator mTORC1, inhibited mTORC1 signaling assessed measurement p-p70S6K p-4E-BP1 combination with strikingly downregulated p-70S6K without affecting total amount proteins. Notably, augmented CCAAT/enhancer-binding protein epsilon (C/EBPepsilon) p27(kip1) c-Myc Furthermore, (5 mg/kg) ability to inhibit proliferation cells growing tumor xenografts immune-deficient nude mice. Taken together, concomitant blockade RA may be promising treatment strategy for individuals AML.

参考文章(29)
Mary-Ann Bjornsti, Peter J Houghton, Lost in translation Cancer Cell. ,vol. 5, pp. 519- 523 ,(2004) , 10.1016/J.CCR.2004.05.027
M Kizaki, MI Dawson, R Heyman, E Elster, R Morosetti, S Pakkala, DL Chen, H Ueno, W Chao, M Morikawa, Y Ikeda, D Heber, M Pfahl, HP Koeffler, Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. Blood. ,vol. 87, pp. 1977- 1984 ,(1996) , 10.1182/BLOOD.V87.5.1977.1977
Takayuki Ikezoe, Eric S. Daar, Jun-ichi Hisatake, Hirokuni Taguchi, H. Phillip Koeffler, HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells. Blood. ,vol. 96, pp. 3553- 3559 ,(2000) , 10.1182/BLOOD.V96.10.3553
Y Ikeda, M Kizaki, H Ueno, Y Yamazoe, M Shimada, N Takayama, A Muto, H Matsushita, H Nakajima, M Morikawa, HP Koeffler, Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood. ,vol. 87, pp. 725- 733 ,(1996) , 10.1182/BLOOD.V87.2.725.BLOODJOURNAL872725
Takayuki Ikezoe, Sakae Tanosaki, Utz Krug, Bingrong Liu, Pinchas Cohen, Hirokuni Taguchi, H. Phillip Koeffler, Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Blood. ,vol. 104, pp. 237- 242 ,(2004) , 10.1182/BLOOD-2003-07-2203
Joseph F. Gera, Ingo K. Mellinghoff, Yijiang Shi, Matthew B. Rettig, Chris Tran, Jung-hsin Hsu, Charles L. Sawyers, Alan K. Lichtenstein, AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. Journal of Biological Chemistry. ,vol. 279, pp. 2737- 2746 ,(2004) , 10.1074/JBC.M309999200
Rolf Schwarzer, Daniel Tondera, Wolfgang Arnold, Klaus Giese, Anke Klippel, Jörg Kaufmann, REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase Oncogene. ,vol. 24, pp. 1138- 1149 ,(2005) , 10.1038/SJ.ONC.1208236
Sigal Gery, Dorothy J. Park, Peter T. Vuong, Renu K. Virk, Claudia I. Muller, Wolf-K. Hofmann, H. Phillip Koeffler, RTP801 is a novel retinoic acid–responsive gene associated with myeloid differentiation Experimental Hematology. ,vol. 35, pp. 572- 578 ,(2007) , 10.1016/J.EXPHEM.2007.01.049
Takayuki Ikezoe, Kentaro Bandobashi, Yang Yang, Seisho Takeuchi, Nobuo Sekiguchi, Shuichi Sakai, H. Phillip Koeffler, Hirokuni Taguchi, HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24 Leukemia Research. ,vol. 30, pp. 1005- 1011 ,(2006) , 10.1016/J.LEUKRES.2005.12.008